← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Mercury General Corporation (MCY) 10-Year Financial Performance & Capital Metrics

MCY • • Insurance & Managed Care
Financial ServicesProperty & Casualty InsurancePersonal Lines InsuranceRegional Personal Lines
AboutMercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States. The company also writes homeowners, commercial automobile, commercial property, mechanical protection, and umbrella insurance products. Its automobile insurance products include collision, property damage, bodily injury, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards; and homeowners insurance products comprise dwelling, liability, personal property, fire, and other hazards. The company sells its policies through a network of independent agents and insurance agencies, as well as directly through internet sales portals in Arizona, California, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas, and Virginia. Mercury General Corporation was founded in 1961 and is headquartered in Los Angeles, California.Show more
  • Revenue $5.48B +18.3%
  • Combined Ratio 89.5% -8.5%
  • Net Income $468M +385.8%
  • Return on Equity 26.78% +326.8%
  • Medical Cost Ratio 82.96% -9.1%
  • Operating Margin 10.5% +388.9%
  • Net Margin 8.55% +310.7%
  • ROA 6.07% +329.1%
  • Equity / Assets 23.42% +7.5%
  • Book Value per Share 35.15 +25.7%
  • Tangible BV/Share 34.24 +26.6%
  • Debt/Equity 0.30 -20.5%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 89.5% combined ratio
  • ✓Strong Piotroski F-Score: 8/9

✗Weaknesses

  • ✗Weak 3Y average ROE of 1.7%
  • ✗High loss ratio of 83.0%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.16%
5Y6.63%
3Y11.1%
TTM6.18%

Profit (Net Income) CAGR

10Y10.15%
5Y7.89%
3Y23.58%
TTM-21.26%

EPS CAGR

10Y10.09%
5Y7.89%
3Y23.55%
TTM-21.41%

ROCE

10Y Avg2.33%
5Y Avg2.12%
3Y Avg-0.49%
Latest7.48%

Peer Comparison

Regional Personal Lines
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
NODKNI Holdings, Inc.274.26M13.3155.466.97%0.87%1.06%13.68%
HMNHorace Mann Educators Corporation1.74B42.8817.298.21%10.24%11.39%25.91%0.42
SAFTSafety Insurance Group, Inc.1.14B76.4916.0019.85%7.13%9.7%10.91%0.06
UFCSUnited Fire Group, Inc.912.14M35.7514.9613.98%8.22%12.38%36.01%0.15
DGICADonegal Group Inc.608.25M19.5812.806.71%8.72%13.73%11.09%0.06
MCYMercury General Corporation5.06B91.3910.8218.27%7.55%19.69%19.58%0.30
KINSKingstone Companies, Inc.225.09M15.9110.757.6%14.2%0.02%24.71%0.17
KMPRKemper Corporation2.26B38.617.86-5.74%5.14%9.14%14.59%0.50

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+3.01B3.23B3.42B3.38B3.97B3.78B3.99B3.64B4.63B5.48B
Revenue Growth %-0%0.07%0.06%-0.01%0.18%-0.05%0.06%-0.09%0.27%0.18%
Medical Costs & Claims+2.68B2.92B3B3.15B3.31B3.02B3.39B4.02B4.23B4.54B
Medical Cost Ratio %----------
Gross Profit+324.57M310M415.73M231.05M664.41M761.38M599.82M-373.76M403.25M932.86M
Gross Margin %----------
Gross Profit Growth %-0.35%-0.04%0.34%-0.44%1.88%0.15%-0.21%-1.62%2.08%1.31%
Operating Expenses+254.01M239.28M248.64M261.67M286.34M302.88M300.51M296.95M303.82M357.98M
OpEx / Revenue %----------
Depreciation & Amortization47.84M53.26M55.34M58.79M64.73M68.46M79.06M82.39M72.24M73.43M
Combined Ratio %----------
Operating Income+70.57M70.72M167.09M-30.61M378.07M458.5M299.31M-670.72M99.43M574.88M
Operating Margin %----------
Operating Income Growth %-0.71%0%1.36%-1.18%13.35%0.21%-0.35%-3.24%1.15%4.78%
EBITDA+118.41M123.98M222.43M28.18M442.8M526.96M378.36M-588.33M171.67M648.31M
EBITDA Margin %----------
Interest Expense3.17M3.96M15.17M17.04M17.04M17.05M17.11M17.23M24.17M30.82M
Non-Operating Income-3.17M-3.96M-15.17M-17.04M-17.04M-17.05M-17.11M-17.23M-24.17M-30.82M
Pretax Income+70.57M70.72M167.09M-30.61M378.07M458.5M299.31M-670.72M99.43M574.88M
Pretax Margin %----------
Income Tax+-3.91M-2.32M22.21M-24.89M57.98M83.89M51.37M-158.04M3.09M106.93M
Effective Tax Rate %----------
Net Income+74.48M73.04M144.88M-5.73M320.09M374.61M247.94M-512.67M96.34M467.95M
Net Margin %----------
Net Income Growth %-0.58%-0.02%0.98%-1.04%56.88%0.17%-0.34%-3.07%1.19%3.86%
EPS (Diluted)+1.351.322.62-0.105.786.774.48-9.261.748.45
EPS Growth %-0.58%-0.02%0.98%-1.04%58.8%0.17%-0.34%-3.07%1.19%3.86%
EPS (Basic)1.351.322.62-0.105.786.774.48-9.261.748.45
Diluted Shares Outstanding55.21M55.3M55.33M55.34M55.36M55.36M55.37M55.37M55.37M55.38M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+4.63B4.79B5.1B5.43B5.89B6.33B6.77B6.51B7.1B8.31B
Asset Growth %0.01%0.03%0.07%0.07%0.08%0.07%0.07%-0.04%0.09%0.17%
Total Investment Assets+3.57B3.55B3.73B3.77B4.81B4.73B5.14B5.03B5.23B6.36B
Long-Term Investments3.38B3.55B3.73B3.77B4.31B4.73B5.14B4.91B5.23B6.08B
Short-Term Investments185.28M375.68M302.71M253.3M494.13M375.61M140.13M122.94M178.49M283.82M
Total Current Assets+449.5M596M594.12M1.39B1.49B00978.82M01.41B
Cash & Equivalents264.22M220.32M291.41M314.29M294.4M348.48M335.56M289.78M550.9M720.26M
Receivables00001000K1000K1000K1000K1000K1000K
Other Current Assets00001.56B-1.37B-1.16B1.25B-1.39B-374.55M
Goodwill & Intangibles+74.5M68.42M63.52M58.33M53.43M54.12M53.05M52.01M51.13M50.48M
Goodwill42.8M42.8M42.8M42.8M42.8M42.8M42.8M42.8M42.8M42.8M
Intangible Assets31.7M25.63M20.73M15.53M10.64M11.32M10.26M9.21M8.33M7.68M
PP&E (Net)157.13M155.91M145.22M153.02M213.9M219.48M223.3M191.63M165.59M151.58M
Other Assets-3.38B-3.55B-3.73B-13.34M-27.96M-5B-5.42B-4.91B-5.45B-6.21B
Total Liabilities2.81B3.04B3.34B3.82B4.09B4.3B4.63B4.99B5.56B6.36B
Total Debt+290M320M371.33M371.73M420.13M416.36M407.51M420.25M587.96M587.71M
Net Debt25.78M99.68M79.92M57.44M125.73M67.88M71.95M130.48M37.06M-132.55M
Long-Term Debt290M320M371.33M371.73M372.13M372.53M372.93M398.33M573.73M574.13M
Short-Term Debt000000011.34M00
Total Current Liabilities+9.04M9.96M61.26M115.07M143.32M00206.82M020.75M
Accounts Payable122.57M112.33M108.25M115.07M143.32M194.42M169.13M151.69M175.22M242.12M
Deferred Revenue000027.96M0042.9M00
Other Current Liabilities-122.57M-122.3M-108.25M-115.07M-27.96M-204.85M-169.13M893K-175.22M-242.12M
Deferred Taxes1000K1000K1000K-1000K1000K1000K1000K1000K00
Other Liabilities2.52B2.72B2.97B3.41B0-457.49M-461.08M4.47B-587.96M5.77B
Total Equity+1.82B1.75B1.76B1.62B1.8B2.03B2.14B1.52B1.55B1.95B
Equity Growth %-0.03%-0.04%0.01%-0.08%0.11%0.13%0.05%-0.29%0.02%0.26%
Shareholders Equity1.82B1.75B1.76B1.62B1.8B2.03B2.14B1.52B1.55B1.95B
Minority Interest0000000000
Retained Earnings1.72B1.66B1.66B1.52B1.7B1.93B2.04B1.42B1.45B1.85B
Common Stock90.98M95.53M97.52M98.03M98.83M98.97M98.94M98.95M98.95M99.7M
Accumulated OCI99.86M000000000
Return on Equity (ROE)0.04%0.04%0.08%-0%0.19%0.2%0.12%-0.28%0.06%0.27%
Return on Assets (ROA)0.02%0.02%0.03%-0%0.06%0.06%0.04%-0.08%0.01%0.06%
Equity / Assets----------
Debt / Equity0.16x0.18x0.21x0.23x0.23x0.20x0.19x0.28x0.38x0.30x
Book Value per Share32.9831.6931.8429.2332.5136.7238.6527.4927.9635.15
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+190.24M287.47M341.4M383.43M519.68M605.62M501.58M352.59M452.99M1.04B
Operating CF Growth %-0.23%0.51%0.19%0.12%0.36%0.17%-0.17%-0.3%0.28%1.29%
Operating CF / Revenue %----------
Net Income74.48M73.04M144.88M-5.73M320.09M374.61M247.94M-512.67M96.34M467.95M
Depreciation & Amortization26.48M26.39M55.34M58.79M64.73M68.46M79.06M82.39M72.24M73.43M
Stock-Based Compensation5.21M142K60K145K123K142K141K15K00
Deferred Taxes105.14M60.22M-86.73M133.52M0-85.73M-111.66M-15K00
Other Non-Cash Items-1.5M-4.06M42.46M13.66M-249.96M14.29M16.32M485.38M-45.95M-90.37M
Working Capital Changes-19.57M131.75M185.39M183.04M384.69M233.84M269.78M297.5M330.36M586.1M
Cash from Investing+-81.68M-226.72M-185.6M-222.44M-401.2M-411.29M-373.67M-316.38M-295.44M-796.66M
Capital Expenditures-20.11M-16.98M-19.44M-27.96M-40.09M-39.95M-41.44M-35.51M-36.81M-46.14M
Acquisitions7.77M14K6.24M0000000
Purchase of Investments-1.72B-1.98B-1.61B-1.73B-1.91B-2.11B-2.42B-2.84B-2.19B0
Sale/Maturity of Investments1000K1000K1000K1000K1000K1000K1000K1000K1000K0
Other Investing2.61M3.6M1.93M10.11M3.71M20.58M17.42M27.88M3.82M-750.52M
Cash from Financing+-134.25M-104.66M-84.71M-138.12M-138.37M-140.25M-140.84M-81.99M103.58M-71.11M
Dividends Paid-136.39M-137.2M-137.89M-138.48M-139.07M-139.64M-140.23M-105.48M-70.32M-70.33M
Share Repurchases0-3.29M00000000
Stock Issued2.11M1.63M2.16M358K00215K00752K
Debt Issuance (Net)01000K1000K00-609K-825K1000K1000K-1000K
Other Financing2.14M5.84M2.16M358K701K00000
Net Change in Cash+-25.69M-43.9M71.09M22.88M-19.89M54.08M-12.92M-45.78M261.13M169.35M
Exchange Rate Effect0000000000
Cash at Beginning289.91M264.22M220.32M291.41M314.29M294.4M348.48M335.56M289.78M550.9M
Cash at End264.22M220.32M291.41M314.29M294.4M348.48M335.56M289.78M550.9M720.26M
Free Cash Flow+170.13M270.49M321.96M355.48M479.59M565.66M460.14M317.08M416.18M990.98M
FCF Growth %-0.23%0.59%0.19%0.1%0.35%0.18%-0.19%-0.31%0.31%1.38%
FCF Margin %----------
FCF per Share3.084.895.826.428.6610.228.315.737.5217.9

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio97.66%97.81%95.11%100.91%90.48%87.88%92.5%118.41%97.85%89.5%
Medical Cost Ratio89.21%90.4%87.83%93.16%83.27%79.88%84.98%110.26%91.29%82.96%
Return on Equity (ROE)4.03%4.09%8.25%-0.34%18.73%19.55%11.88%-28%6.28%26.78%
Return on Assets (ROA)1.61%1.55%2.93%-0.11%5.65%6.13%3.79%-7.72%1.41%6.07%
Equity / Assets39.34%36.59%34.53%29.77%30.56%32.12%31.6%23.37%21.79%23.42%
Book Value / Share32.9831.6931.8429.2332.5136.7238.6527.4927.9635.15
Debt / Equity0.16x0.18x0.21x0.23x0.23x0.20x0.19x0.28x0.38x0.30x
Revenue Growth-0.08%7.26%5.83%-1.05%17.53%-4.73%5.52%-8.77%27.08%18.27%

Frequently Asked Questions

Valuation & Price

Mercury General Corporation (MCY) has a price-to-earnings (P/E) ratio of 10.8x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Mercury General Corporation (MCY) grew revenue by 18.3% over the past year. This is strong growth.

Yes, Mercury General Corporation (MCY) is profitable, generating $439.6M in net income for fiscal year 2024 (8.5% net margin).

Dividend & Returns

Yes, Mercury General Corporation (MCY) pays a dividend with a yield of 1.39%. This makes it attractive for income-focused investors.

Mercury General Corporation (MCY) has a return on equity (ROE) of 26.8%. This is excellent, indicating efficient use of shareholder capital.

Industry Metrics

Mercury General Corporation (MCY) has a combined ratio of 89.5%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.